EDX110 Randomized Control Trial for Treatment of DFUs

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
ConvaTec Inc.
Study ID
NCT07209358
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • EDX110 — DEVICE
    EDX110 wound dressing system EDX110 is a dressing system comprising two layers that allows the generation of nitric oxide (NO) in situ, enables adequate moisture management and facilitates debridement

Study Details

Prospective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard of care leads to an improvement in diabetic foot ulcers healing compared to just using standard of care.

Key Dates

Start date
Oct 30, 2025
Status verified
Dec 2025
Primary completion
Dec 1, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
298 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: EDX110 with Standard of Care (SOC)
    Diabetic Foot Ulcer (DFU) DFU treatment with EDX110 wound dressing and SOC
  • No Intervention: Standard of Care (SOC)
    Diabetic Foot Ulcer (DFU) DFU treatment with using only traditional Standard of Care (SOC)

Primary Outcome Measure

Wound Closure [ Time Frame: 16 Weeks ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Axentra BioPhoenixArizona85053
Rajashekhar Ittedi
857-746-9255
Kanchan Verandani
4192084421
Clemente Clinical ResearchSanta AnaCalifornia92704
Scott Mathis
949-280-8719
Ana Chen
714-442-0931
ILD Research CenterVistaCalifornia92081
Eric Martinez
760-350-5080
Irene Vayser
619-917-0543
Futuro Clinical TrialsMcAllenTexas78501
Pedro Gonzalez
956-494-3686
Caitlyn Salinas
9567760901

Find similar trials in Phoenix, AZ

Related Studies